Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience

Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience

PURPOSEWe aimed to describe the frequency of adverse events after computed tomography (CT) fluoroscopy-guided irreversible electroporation (IRE) of malignant hepatic tumors and their risk factors.METHODSWe retrospectively analyzed 85 IRE ablation procedures of 114 malignant liver tumors (52 primary...

Full description

Bibliographic Details
Main Authors:	Marco Dollinger, Lukas Philipp Beyer, Michael Haimerl, Christoph Niessen, Ernst-Michael Jung, Florian Zeman, Christian Stroszczynski, Philipp Wiggermann
Format:	Article
Language:	English
Published:	Galenos Publishing House 2015-11-01
Series:	Diagnostic and Interventional Radiology
Online Access:	http://www.dirjournal.org/archives/archive-detail/article-preview/adverse-effects-of-irreversible-electroporation-of/55613

Similar Items

Similar complication rates for irreversible electroporation and thermal ablation in patients with hepatocellular tumors
by: Verloh Niklas, et al.
Published: (2023-03-01)

Similar complication rates for irreversible electroporation and thermal ablation in patients with hepatocellular tumors
by: Verloh Niklas, et al.
Published: (2019-03-01)

Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
by: Marco Dollinger, et al.
Published: (2015-01-01)

Stereotactically-navigated percutaneous Irreversible Electroporation (IRE) compared to conventional IRE: a prospective trial
by: Lukas P. Beyer, et al.
Published: (2016-08-01)

Long-term survival after percutaneous irreversible electroporation of inoperable colorectal liver metastases
by: Schicho A, et al.
Published: (2018-12-01)

Detection of Incomplete Irreversible Electroporation (IRE) and Microwave Ablation (MWA) of Hepatocellular Carcinoma (HCC) Using Iodine Quantification in Dual Energy Computed Tomography (DECT)
by: Wolf Bäumler, et al.
Published: (2022-04-01)

Evaluation of Alterations to Bile Ducts and Laboratory Values During the First 3 Months After Irreversible Electroporation of Malignant Hepatic Tumors
by: Bäumler W, et al.
Published: (2020-09-01)

Incidence and evolution of venous thrombosis during the first 3 months after irreversible electroporation of malignant hepatic tumours
by: W. Bäumler, et al.
Published: (2019-12-01)

Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI.
by: Michael Haimerl, et al.
Published: (2014-01-01)

Continuous Dynamic Registration of Microvascularization of Liver Tumors with Contrast-Enhanced Ultrasound
by: Lukas Philipp Beyer, et al.
Published: (2014-01-01)

Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI.
by: Michael Haimerl, et al.
Published: (2013-01-01)

Irreversible electroporation for prostate cancer using PSMA PET-CT
by: Dongho Shin, et al.
Published: (2023-03-01)

Irreversible electroporation for treating liver metastases: Interventional procedures guidance [IPG445]
by: National Institute for Health and Care Excellence, CA, et al.
Published: (2013)

Irreversible electroporation for treating pancreatic cancer: Interventional procedures guidance [IPG579]
by: Powell, J, et al.
Published: (2017)

Irreversible electroporation for treating renal cancer: Interventional procedures guidance [IPG443]
by: National Institute for Health and Care Excellence, CA, et al.
Published: (2013)

Irreversible Electroporation for Prostate Cancer
by: Sean Ong, et al.
Published: (2021-05-01)

Tumor ablation with irreversible electroporation.
by: Bassim Al-Sakere, et al.
Published: (2007-11-01)

Color coded perfusion imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following trans-arterial chemoembolization (TACE) of hepatocellular carcinoma.
by: Janine Rennert, et al.
Published: (2019-01-01)

MRI and CT in the follow-up after irreversible electroporation of small renal masses
by: Mara Buijs, et al.
Published: (2021-09-01)

Advances in irreversible electroporation for prostate cancer
by: Xinyu Liu, et al.
Published: (2024-11-01)

Uncertainty Quantification in Irreversible Electroporation Simulations
by: Nicholas Labarbera
Published: (2017-05-01)

The effects of irreversible electroporation (IRE) on nerves.
by: Wei Li, et al.
Published: (2011-01-01)

Conductivity Variation during Irreversible Electroporation
by: Xu Chao, et al.
Published: (2021-01-01)

Human in vitro assay for irreversible electroporation cardiac ablation
by: Maura Casciola, et al.
Published: (2023-01-01)

Concept for parallel placement of flexible needles for Irreversible Electroporation
by: Arif Hanbal, et al.
Published: (2021-10-01)

Transobturator Bypass Utilizing Fluoroscopic Guidance
by: P.S. Lajos, et al.
Published: (2016-01-01)

Irreversible electroporation for treating primary lung cancer and metastases in the lung: Interventional procedures guidance [IPG441]
by: National Institute for Health and Care Excellence, CA, et al.
Published: (2013)

IRREVERSIBLE ELECTROPORATION FOR CANCER TREATMENT: A REVIEW
by: Tihomir Georgiev, et al.
Published: (2023-12-01)

Irreversible electroporation of hepatocellular carcinoma: the role of ultrasonography
by: Katsutoshi Sugimoto, et al.
Published: (2020-07-01)

Initial experience with irreversible electroporation of liver tumours
by: David Stillström, et al.
Published: (2019-01-01)

Immunological effect of irreversible electroporation on hepatocellular carcinoma
by: Xiaoxia Guo, et al.
Published: (2021-04-01)

Is electrocardiogram-gated irreversible electroporation still effective in liver ablation? A validation study in swine liver irreversible electroporation model
by: Edward Wolfgang Lee, et al.
Published: (2023-07-01)

Irreversible electroporation of human primary uveal melanoma in enucleated eyes.
by: Yossi Mandel, et al.
Published: (2013-01-01)

Emphysematous cystitis: mortality, risk factors, and pathogens of a rare disease
by: Andreas Schicho, et al.
Published: (2017-04-01)

Is Fluoroscopic Guidance Needed for Palliative Esophageal Stenting?
by: Praveer Rai
Published: (2019-04-01)

A Single-Cell Electroporation Model for Quantitatively Estimating the Pore Area Ratio by High-Frequency Irreversible Electroporation
by: Lujia Ding, et al.
Published: (2023-01-01)

T-Fastener Gastropexy and Percutaneous Gastrostomy Under CT-Fluoroscopic Guidance in a Patient with Partial Gastrectomy
by: Siu-Cheung Chan, et al.
Published: (2006-01-01)

A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety
by: Ziyin Wang, et al.
Published: (2021-02-01)

Irreversible Electroporation Ablation for Atrial Fibrillation: Status and Challenges
by: Fei Xie, et al.
Published: (2022-03-01)

Rat liver regeneration following ablation with irreversible electroporation
by: Alexander Golberg, et al.
Published: (2016-01-01)